Annual Shareholders Equity
$2.53 M
-$19.09 M-88.28%
31 December 2022
Summary:
Bellerophon Therapeutics annual stockholders equity is currently $2.53 million, with the most recent change of -$19.09 million (-88.28%) on 31 December 2022. During the last 3 years, it has fallen by -$35.72 million (-93.37%). BLPH annual shareholders equity is now -93.37% below its all-time high of $38.25 million, reached on 31 December 2020.BLPH Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$3.72 M
-$1.90 M-33.79%
30 September 2023
Summary:
Bellerophon Therapeutics quarterly stockholders equity is currently $3.72 million, with the most recent change of -$1.90 million (-33.79%) on 30 September 2023. BLPH quarterly shareholders equity is now -94.03% below its all-time high of $62.39 million, reached on 31 March 2015.BLPH Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLPH Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -93.4% | -85.6% |
| 5 y5 years | -34.3% | -49.3% |
BLPH Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -93.4% | at low | -85.6% | +46.9% |
| 5 y | 5 years | -93.4% | at low | -93.0% | +73.5% |
| alltime | all time | -93.4% | +116.1% | -94.0% | +123.7% |
Bellerophon Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $3.72 M(-33.8%) |
| June 2023 | - | $5.62 M(-47.0%) |
| Mar 2023 | - | $10.60 M(+318.4%) |
| Dec 2022 | $2.53 M(-88.3%) | $2.53 M(-65.9%) |
| Sept 2022 | - | $7.43 M(-39.5%) |
| June 2022 | - | $12.28 M(-24.1%) |
| Mar 2022 | - | $16.17 M(-25.2%) |
| Dec 2021 | $21.62 M(-43.5%) | $21.62 M(-16.2%) |
| Sept 2021 | - | $25.79 M(-14.3%) |
| June 2021 | - | $30.10 M(-9.2%) |
| Mar 2021 | - | $33.13 M(-13.4%) |
| Dec 2020 | $38.25 M(+965.1%) | $38.25 M(-16.6%) |
| Sept 2020 | - | $45.87 M(-14.1%) |
| June 2020 | - | $53.40 M(+2388.4%) |
| Mar 2020 | - | $2.15 M(-40.2%) |
| Dec 2019 | $3.59 M(-6.9%) | $3.59 M(-51.1%) |
| Sept 2019 | - | $7.35 M(-35.9%) |
| June 2019 | - | $11.46 M(+11.2%) |
| Mar 2019 | - | $10.30 M(+167.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $3.86 M(-248.7%) | $3.86 M(-1.8%) |
| Sept 2018 | - | $3.93 M(-150.5%) |
| June 2018 | - | -$7.78 M(-450.7%) |
| Mar 2018 | - | $2.22 M(-185.5%) |
| Dec 2017 | -$2.59 M(-114.4%) | -$2.59 M(-116.5%) |
| Sept 2017 | - | $15.67 M(-2091.6%) |
| June 2017 | - | -$787.00 K(-198.4%) |
| Mar 2017 | - | $800.00 K(-95.6%) |
| Dec 2016 | $17.99 M(-40.7%) | $17.99 M(-0.0%) |
| Sept 2016 | - | $18.00 M(-10.3%) |
| June 2016 | - | $20.07 M(-16.0%) |
| Mar 2016 | - | $23.90 M(-21.2%) |
| Dec 2015 | $30.34 M(+32.3%) | $30.34 M(-25.1%) |
| Sept 2015 | - | $40.52 M(-20.9%) |
| June 2015 | - | $51.22 M(-17.9%) |
| Mar 2015 | - | $62.39 M(+172.0%) |
| Dec 2014 | $22.94 M(-245.8%) | $22.94 M(-34.7%) |
| Sept 2014 | - | $35.10 M(-323.0%) |
| Dec 2013 | -$15.74 M(+41.6%) | -$15.74 M |
| Dec 2012 | -$11.12 M | - |
FAQ
- What is Bellerophon Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bellerophon Therapeutics?
What is Bellerophon Therapeutics annual stockholders equity?
The current annual shareholders equity of BLPH is $2.53 M
What is the all time high annual shareholders equity for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual stockholders equity is $38.25 M
What is Bellerophon Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of BLPH is $3.72 M
What is the all time high quarterly shareholders equity for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly stockholders equity is $62.39 M